(5S)-3-(4-fluorophenyl)-5-[1-(1H-imidazol-5-ylmethyl)piperidin-4-yl]-5-methyl-1,3-oxazolidin-2-one
C19H23FN4O2 — CID 124980380
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-3-(4-fluorophenyl)-5-[1-(1H-imidazol-5-ylmethyl)piperidin-4-yl]-5-methyl-1,3-oxazolidin-2-one
(5S)-3-(4-fluorophenyl)-5-[1-(1H-imidazol-5-ylmethyl)piperidin-4-yl]-5-methyl-1,3-oxazolidin-2-one (PubChem CID 124980380) has the molecular formula C19H23FN4O2 and a molecular weight of 358.42 g/mol. Its IUPAC name is (5S)-3-(4-fluorophenyl)-5-[1-(1H-imidazol-5-ylmethyl)piperidin-4-yl]-5-methyl-1,3-oxazolidin-2-one.
Molecular Properties
| Compound Name | (5S)-3-(4-fluorophenyl)-5-[1-(1H-imidazol-5-ylmethyl)piperidin-4-yl]-5-methyl-1,3-oxazolidin-2-one |
|---|---|
| PubChem CID | 124980380 |
| Molecular Formula | C19H23FN4O2 |
| Molecular Weight | 358.42 g/mol |
| Exact Mass | 358.18 |
| IUPAC Name | (5S)-3-(4-fluorophenyl)-5-[1-(1H-imidazol-5-ylmethyl)piperidin-4-yl]-5-methyl-1,3-oxazolidin-2-one |
| SMILES | C[C@]1(C2CCN(Cc3cnc[nH]3)CC2)CN(c2ccc(F)cc2)C(=O)O1 |
| InChI | InChI=1S/C19H23FN4O2/c1-19(12-24(18(25)26-19)17-4-2-15(20)3-5-17)14-6-8-23(9-7-14)11-16-10-21-13-22-16/h2-5,10,13-14H,6-9,11-12H2,1H3,(H,21,22)/t19-/m1/s1 |
| InChIKey | MIJMHAVONAURPJ-LJQANCHMSA-N |
| XLogP | 3.18 |
| TPSA | 61.46 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 358.42 |
| LogP ≤ 5 | 3.18 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 124980380 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.